The company said it also saw record cash collections in the quarter despite challenges caused by regulatory change.
The lawsuit alleges that the two companies conspired to prevent a competitor from taking over a LabCorp lab services contract.
If successful, the blockchain pilot could serve as a model for future collaborations, alliance participants said.
As payors increase controls over reimbursements for genetic lab testing, labs are increasingly using genetic counselors as middlemen in lab test reimbursements, genetic counselors say.
LabCorp also plans to introduce an in-home testing device sometime this quarter, company officials said.
PriorAuthNow's platform will be integrated with Xifin RPM 9's intelligent automation. According to Xifin, $31 billion is spent each year on prior authorizations.
Coming one year after LabCorp's acquisition of Mount Sinai's Clinical Outreach business, the new partnership will standardize lab operations at seven hospitals.
The insurer alleges the labs overbilled, double-billed, and billed for testing that was not performed through a scheme that involved kickbacks and misrepresentation.
Digital pathology has been relegated to research use only in many smaller labs, but an FDA approval last year, and more options targeted to them, may change that.
The expansion into Florida more than doubles the size of the LabCorp at Walgreens network from six locations to 16.
Big data, automation, and low-tech changes to workspaces have combined to reduce ARUP's incidences of lost lab specimens.
The company anticipates that the negative impact of PAMA will be offset by an estimated $180 million in tax savings due to tax reform.
The platform, which was first developed to transmit flu data to the CDC, is expanding to multiple use cases and multiple users.
The deal also included the acquisition of Cascade Cytology Reference Laboratories, which provides cytology support to physicians in the Pacific Northwest.
Both sides have filed competing arguments requesting the judge rule on the case without a trial.
Using an immunoassay as an initial screening tool saved approximately $36,000 over multiplex PCR panel use alone when performed in a period of high flu prevalence.
Quest, Humana, Multiplan, Optum, and UnitedHealthcare are launching a pilot program directed at data quality and administrative costs related to changes to healthcare provider demographic data.
Practice recommendations could serve as a guide for labs considering using the high-sensitivity assays as they become available, authors said.
CDC's MOU will seek to codify lessons learned from the public and commercial lab partnership during the Zika outbreak in the US in 2016.
Basel Batarseh was sentenced to 18 months in prison and fined $7,500 for his role in the scheme operated by the now-defunct Biodiagnostic Laboratory Services.